News GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Stocks

GLAXO

INE159A01016

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:05:07 2026-07-01 EDT			5-day change	1st Jan Change
2,464.70 ^INR	+0.59%		+2.84%	-0.36%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

All News

Mentions Relevance

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT
05-13	GlaxoSmithKline Pharmaceuticals March-quarter consol profit 2.78 billion rupees	RE
05-13	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
05-12	GlaxoSmithKline Pharmaceuticals Limited announces Annual dividend, payable on July 30, 2026	CI
04-21	Glaxosmithkline Pharmaceuticals Limited Announces Appointment of Vinay Subramanian as Commercial Head ? Oncology and Senior Management Personnel, Effective April 20, 2026	CI
03-31	GlaxoSmithKline Pharmaceuticals receives TDS demand liability of 20.1 million rupees	RE
03-24	GlaxoSmithKline Pharmaceuticals Ltd receives final order with tax demand liability of 232.1 mln rupees for AY 2023-24	RE
03-16	GlaxoSmithKline Pharmaceuticals Ltd says Juby Chandy resigns as whole-time director and CFO	RE
03-02	GlaxoSmithKline Pharmaceuticals Names CFO	MT
03-02	GlaxoSmithKline Pharmaceuticals says Ronojit Biswas appointed as whole-time director & CFO	RE
03-02	GlaxoSmithKline Pharmaceuticals Limited Announces Chief Financial Officer Changes	CI
03-02	GlaxoSmithKline Pharmaceuticals Limited Announces Executive Changes	CI
02-23	GlaxoSmithKline Pharmaceuticals gets order with total tax demand of 37.9 million rupees including tax, penalty	RE
02-09	GlaxoSmithKline Pharmaceuticals Limited - Shareholder/Analyst Call
02-09	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
02-09	GlaxoSmithKline Pharmaceuticals Ltd Dec-quarter consol profit 2.96 billion rupees	RE
12-31	GlaxoSmithKline Pharmaceuticals gets tax demand of 85.7 million rupees	RE
12-22	GlaxoSmithKline Pharmaceuticals Ltd receives tax demand order of 9 million rupees	RE
11-06	GlaxoSmithKline Pharma Q2 consol profit 2.57 billion rupees	RE
25-10-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resumption Of Sukanya Choudhury As Executive Vice President - Regulatory Affairs	CI
25-09-08	Glaxosmithkline pharmaceuticals gets tax demand of total 18.1 million rupees	RE
25-08-01	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-07-09	Glaxosmithkline Pharmaceuticals Limited Appoints Vishwanath Swarup as Commercial Head - General Medicines, Effective July 9, 2025	CI
25-06-27	Glaxosmithkline Pharmaceuticals Limited Approves Final Dividend for the Financial Year Ended March 31, 2025	CI